GlassScriptPhysician profile
Jason Brandt
NPI 1952368565
$103,774.99
in general payments reported to CMS, 2019-2025
37 companies · $8,352 in 2025
The $8,352 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,417 · 2020: $5,955 · 2021: $14K · 2022: $19K · 2023: $14K · 2024: $40K · 2025: $8,352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35K · Travel and Lodging: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,000 · Food and Beverage: $5,520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $34,725.00 |
| Travel and Lodging | $14,723.74 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,000.00 |
| Food and Beverage | $5,519.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $95,300.70 | 2019-2025 | Journey II, Real Intelligence, Ri Hip Navigation |
| Stryker Corporation | $2,305.67 | 2019-2025 | Mako, Axsos, Gamma |
| Conformis, INC. | $1,663.27 | 2019-2021 | |
| Midsouth Orthopedics INC. | $1,407.69 | 2020-2024 | |
| Arthrex, INC. | $678.54 | 2020-2024 | Distal Extremities Implants Trauma, Arthrex |
| Amgen INC. | $498.61 | 2019-2023 | Prolia, Evenity |
| Djo, LLC | $309.05 | 2021-2025 | Cmf |
| Orthalign INC | $163.24 | 2024 | Orthalign Plus |
| Trice Medical, INC. | $151.37 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $146.15 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $141.48 | 2021-2024 | Zilretta, Exparel, Iovera |
| Davol INC. | $115.25 | 2024 | Arista Ah Flexitip, Tridyne Vascular Sealant |
| Horizon Therapeutics Plc | $112.48 | 2021-2022 | |
| Pacira Therapeutics, INC. | $106.42 | 2019-2021 | |
| Depuy Synthes Sales INC. | $100.69 | 2019-2023 | Orthovisc, Monovisc |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $65.86 | 2021-2024 | Euflexxa |
| Bioventus LLC | $61.25 | 2020-2025 | Exogen Ultrasound Bone Healing System |
| Heron Therapeutics, INC. | $55.40 | 2024 | Zynrelef |
| Astrazeneca Pharmaceuticals LP | $38.80 | 2023-2025 | Wainua |
| Radius Health, INC. | $36.34 | 2021 | |
| Ethicon US, LLC | $34.32 | 2024-2025 | Vistaseal, Echelon; Endopath |
| Pfizer INC. | $32.38 | 2020 | |
| Innovation Technologies INC | $31.86 | 2025 | Irrisept |
| Organogenesis INC. | $31.05 | 2025 | Puraply Wound Matrix |
| Karl Storz Endoscopy-America | $23.79 | 2025 | Image 1 S |
| Baudax Bio INC. | $20.14 | 2022 | |
| Biowound Solutions, INC. | $15.92 | 2025 | Bio-Connekt |
| Urgo Medical North America, LLC | $15.66 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Endo USA, INC. | $15.28 | 2025 | Xiaflex |
| Osiris Therapeutics INC. | $14.87 | 2019 | |
| Kci USA, INC. | $14.56 | 2020 | |
| Convatec INC. | $14.37 | 2022 | |
| Medtronic, INC. | $13.86 | 2024 | Plasmablade(Tm) |
| Endo Pharmaceuticals INC. | $13.77 | 2022 | |
| Triad Life Sciences INC. | $12.50 | 2021 | |
| Acera Surgical, INC. | $12.40 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Brandt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.